SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-20-073907
Filing Date
2020-03-16
Accepted
2020-03-16 07:52:49
Documents
69
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d862694d10k.htm 10-K 1001823
2 EX-21.1 d862694dex211.htm EX-21.1 2262
3 EX-23.1 d862694dex231.htm EX-23.1 2363
4 EX-31.1 d862694dex311.htm EX-31.1 10782
5 EX-31.2 d862694dex312.htm EX-31.2 10827
6 EX-32.1 d862694dex321.htm EX-32.1 4900
7 EX-32.2 d862694dex322.htm EX-32.2 4876
  Complete submission text file 0001193125-20-073907.txt   5857385

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT galt-20191231.xml EX-101.INS 1059810
9 XBRL TAXONOMY EXTENSION SCHEMA galt-20191231.xsd EX-101.SCH 60864
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20191231_cal.xml EX-101.CAL 26439
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20191231_def.xml EX-101.DEF 390340
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20191231_lab.xml EX-101.LAB 479611
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20191231_pre.xml EX-101.PRE 428240
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 20715313
SIC: 2834 Pharmaceutical Preparations